Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers.
Jansen M, Warrington S, Dishy V, Ohwada S, Johnson L, Brown K, Ishizuka H. Jansen M, et al. Among authors: dishy v. Clin Pharmacol Drug Dev. 2018 Aug;7(6):661-669. doi: 10.1002/cpdd.448. Epub 2018 Apr 17. Clin Pharmacol Drug Dev. 2018. PMID: 29663714 Clinical Trial.
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug-Drug Interaction Studies in Healthy Subjects.
Jansen M, Mendell J, Currie A, Dow J, He L, Merante D, Dishy V, Ishizuka H, Zahir H. Jansen M, et al. Among authors: dishy v. Clin Pharmacol Drug Dev. 2018 Aug;7(6):597-612. doi: 10.1002/cpdd.582. Epub 2018 Jun 5. Clin Pharmacol Drug Dev. 2018. PMID: 29870596 Clinical Trial.
Effect of DS-8500a, a Novel G Protein-Coupled Receptor 119 Agonist, on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Subjects.
Maekawa Y, Furuie H, Kato M, Myobatake Y, Kamiyama E, Watanabe A, Shiosakai K, Taguchi T, Bass R, Zhou J, Dishy V, Warren V, Vashi V, Ishizuka H. Maekawa Y, et al. Among authors: dishy v. Clin Drug Investig. 2019 Oct;39(10):967-978. doi: 10.1007/s40261-019-00825-1. Clin Drug Investig. 2019. PMID: 31321631 Clinical Trial.
Pharmacokinetics and Pharmacodynamics of the Nonvitamin K Antagonist Oral Anticoagulant Edoxaban When Administered Alone or After Switching from Rivaroxaban or Dabigatran Etexilate in Healthy Subjects.
Parasrampuria DA, Weilert D, Maa JF, Dishy V, Kochan J, Shi M, Brown KS. Parasrampuria DA, et al. Among authors: dishy v. Clin Drug Investig. 2016 Feb;36(2):127-36. doi: 10.1007/s40261-015-0357-8. Clin Drug Investig. 2016. PMID: 26597179 Free PMC article.
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS-1040, an Inhibitor of the Activated Form of Thrombin-Activatable Fibrinolysis Inhibitor, in Healthy Subjects.
Zhou J, Limsakun T, Yin O, Warren V, Zamora C, Atiee G, Kochan J, Pav J, Kobayashi F, Vashi V, Dishy V. Zhou J, et al. Among authors: dishy v. J Clin Pharmacol. 2019 Dec;59(12):1669-1677. doi: 10.1002/jcph.1474. Epub 2019 Jun 27. J Clin Pharmacol. 2019. PMID: 31243790 Clinical Trial.
48 results